@troycandy's peptide journey claims need more context

What did @troycandy actually say?

Troy runs through a personal two-year body recomposition journey involving several compounds: what sounds like Retatrutide (he calls it "Reda True Chire"), TRT (testosterone replacement therapy), GHK-Cu, and MT2 (Melanotan 2). He frames it clearly as personal experience, not advice, which is the right call. His main claims are that TRT improved sleep, recovery, and libido with no side effects on an every-other-day protocol; that the GLP-1-adjacent peptide killed cravings and helped him lose fat in four weeks; that GHK-Cu improved skin and thickened his hair; and that MT2 darkened his skin, reduced burning, and boosted libido. He is upfront that he is not a doctor. That transparency matters, but it does not make every claim accurate.

Does the science back this up?

Some of it, partially. TRT on a frequent low-dose schedule to minimize peaks and troughs is actually a legitimate clinical strategy. Studies like Rastrelli et al. (2018, Journal of Endocrinological Investigation) confirm that frequent smaller injections can smooth out serum testosterone fluctuations and reduce side effects like mood swings and erythrocytosis. That part tracks.

On Retatrutide specifically, early phase 2 trial data published by Jastreboff et al. (2023, NEJM) showed significant weight loss and appetite suppression in clinical participants, which aligns with his reported craving reduction. But the compound is still investigational. No regulatory body has approved it. What he is injecting is a research chemical of unverified purity and dosage accuracy.

GHK-Cu has some interesting preliminary data. Pickart et al. (2015, Journal of Aging Research) documented effects on skin remodeling and collagen production in lab settings. Hair thickening has some support from Procyte-era studies, but large, controlled human trials are absent. His claims about skin and hair are biologically plausible, not proven. MT2 is a different story. It is not approved anywhere as a cosmetic tanning agent, and its libido effects are real but also linked to priapism and uncontrolled erections in clinical reports.

What did they get wrong (or right)?

He gets credit for the diet-first, training-first framing. He put in two years of actual work before attributing results to peptides. That is rare and worth acknowledging.

What he gets wrong, or at least undersells, is the risk profile. Calling his TRT experience "no side effects" is not universal. TRT suppresses endogenous testosterone production, raises hematocrit, and can affect fertility. Basaria et al. (2010, NEJM) had to stop a TRT trial early due to cardiovascular events in older men. Younger, healthier users face different risks, but "clean, easy" is not a complete picture.

His Retatrutide dosing discussion is also a concern. He mentions specific unit amounts that listeners will almost certainly attempt to replicate. He says "I'm not advising this," but describing a dose adjustment protocol in detail is functionally the same thing for a 250K-view audience. Retatrutide is not standardized for consumer use. Batch potency varies widely in the gray market.

The MT2 libido claim is real but incomplete. The mechanism involves melanocortin receptors and can cause non-selective activation leading to side effects including nausea, spontaneous erections, and increased blood pressure. That context is missing entirely.

What should you actually know?

These compounds exist on a regulatory spectrum from "used off-label by clinicians" (testosterone) to "unapproved research chemical" (MT2, Retatrutide). That distinction is not semantic. It affects what you actually receive when you order them, how they are dosed, and what recourse you have if something goes wrong.

• Retatrutide is in phase 3 trials as of 2024. It is not approved for human use outside of clinical trials. Gray-market versions have no guaranteed purity or concentration.
• TRT requires baseline bloodwork, ongoing monitoring of hematocrit, PSA, and lipids. Self-administering without labs is genuinely risky over time.
• GHK-Cu evidence is interesting but mostly preclinical. Claiming it thickens hair is plausible, not proven in large human studies.
• MT2 is banned in several countries specifically because of its unpredictable side effect profile and lack of safety data. Using it for cosmetic tanning is off-label in every jurisdiction.

Troy's transparency about his non-expert status is genuine. But 250K views means a lot of people will take "10 units twice a week" as a starting point. That is where personal experience content becomes a public health issue, regardless of disclaimers.